Molecular basis and current treatment for alcoholic liver disease

International Journal of Environmental Research and Public Health

Volumn 7, Issue 5, 2010, Pages 1872-1888

  Miranda Mendez, Alejandra ^a   Lugo Baruqui, Alejandro ^a,b   Armendariz Borunda, Juan ^a,b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b OPD Civil Hospital Juan I Menchaca   (Mexico)

Author keywords

Alcohol; Alcoholic liver disease; Alcoholism; Cirrhosis; Fibrosis

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ACAMPROSATE; BACLOFEN; CORTICOSTEROID; DISULFIRAM; DULOXETINE; NALTREXONE; ONDANSETRON; PENTOXIFYLLINE; PIRFENIDONE; PLACEBO;

ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; ALCOHOLICS ANONYMOUS; ALCOHOLISM; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DOPPLER ECHOGRAPHY; GENETIC PREDISPOSITION; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MOLECULAR GENETICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; REVIEW; STEATOSIS; UNSPECIFIED SIDE EFFECT; CAUSE OF DEATH; GENETICS; LIVER DISEASES, ALCOHOLIC; MORTALITY; WORLD HEALTH ORGANIZATION;

CAUSE OF DEATH; HUMANS; LIVER DISEASES, ALCOHOLIC; WORLD HEALTH ORGANIZATION;

EID: 77954791557     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph7051872     Document Type: Review

References (49)

1. Global Status Report on Alcohol 2004; World Health Organization, Dept. of Mental Health and Substance Abuse: Geneva, Switzerland, 2004; p. 88.
2. Alcohol and Injury in Emergency Departments. Summary of the Report From the WHO Collaborative on Alcohol and Injuries; World Health Organization, Dept. Of Mental Health and Substance Abuse, Dept. of Injuries and Violence Prevention.: Geneva, Switzerland, 2007; p. 13.
3. Mann, R.E.; Smart, R.G.; Govoni, R. The epidemiology of alcoholic liver disease. Alcohol. Res. Health 2003, 27, 209-219.
4. Malhi, H.; Gores, G.J. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008, 134, 1641-1654.
5. Song, B.J.; Moon, K.H.; Olsson, N.U.; Salem, N., Jr. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J. Hepatol. 2008, 49, 262-273.
6. Lucey, M.R.; Mathurin, P.; Morgan, T.R. Alcoholic hepatitis. N. Engl. J. Med. 2009, 360, 2758-2769.
7. Siu, L.; Foont, J.; Wands, J.R. Hepatitis C virus and alcohol. Semin. Liver. Dis. 2009, 29, 188-199.
8. Mayfield, R.D.; Harris, R.A.; Schuckit, M.A. Genetic factors influencing alcohol dependence. Br. J. Pharmacol. 2008, 154, 275-287.
9. Day, C.P.; Bassendine, M.F. Genetic predisposition to alcoholic liver disease. Gut. 1992, 33, 1444-1447.
10. Ducci, F.; Goldman, D. Genetic approaches to addiction: Genes and alcohol. Addiction 2008, 103, 1414-1428.
11. Michitaka, K.; Nishiguchi, S.; Aoyagi, Y.; Hiasa, Y.; Tokumoto, Y.; Onji, M. Etiology of liver cirrhosis in Japan: A nationwide survey. J. Gastroenterol. 2010, 45, 86-94.
12. Strat, Y.L.; Ramoz, N.; Schumann, G.; Gorwood, P. Molecular genetics of alcohol dependence and related endophenotypes. Curr. Genomics. 2008, 9, 444-451.
13. Noble, E.P. The D2 dopamine receptor gene: A review of association studies in alcoholism and phenotypes. Alcohol 1998, 16, 33-45.
14. Polich, J.; Bloom, F.E. P300, alcoholism heritability, and stimulus modality. Alcohol 1999, 17, 149-156.
15. Vaughn, M.G.; Beaver, K.M.; DeLisi, M.; Howard, M.O.; Perron, B.E. Dopamine D4 receptor gene exon III polymorphism associated with binge drinking attitudinal phenotype. Alcohol 2009, 43, 179-184.
16. Namkoong, K.; Cheon, K.A.; Kim, J.W.; Jun, J.Y.; Lee, J.Y. Association study of dopamine D2, D4 receptor gene, GABAA receptor beta subunit gene, serotonin transporter gene polymorphism with children of alcoholics in Korea: a preliminary study. Alcohol 2008, 42, 77-81.
17. Wu, D.; Cederbaum, A.I. Alcohol, oxidative stress, and free radical damage. Alcohol. Res. Health 2003, 27, 277-284.
18. Lu, Y.; Cederbaum, A.I. CYP2E1 and oxidative liver injury by alcohol. Free Radic. Biol. Med. 2008, 44, 723-738.
19. Bousquet-Dubouch, M.P.; Nguen, S.; Bouyssie, D.; Burlet-Schiltz, O.; French, S. W.; Monsarrat, B.; Bardag-Gorce, F. Chronic ethanol feeding affects proteasome-interacting proteins. Proteomics 2009, 9, 3609-3622.
20. Crossley, I.R.; Neuberger, J.; Davis, M.; Williams, R.; Eddleston, A.L. Ethanol metabolism in the generation of new antigenic determinants on liver cells. Gut 1986, 27, 186-189.
21. Cubero, F.J.; Urtasun, R.; Nieto, N. Alcohol and liver fibrosis. Semin. Liver Dis. 2009, 29, 211-221.
22. Cahill, A.; Cunningham, C.C.; Adachi, M.; Ishii, H.; Bailey, S.M.; Fromenty, B.; Davies, A. Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcohol. Clin. Exp. Res. 2002, 26, 907-915.
23. Gyamfi, M.A.; Damjanov, I.; French, S.; Wan, Y.J. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury. Biochem. Pharmacol. 2008, 75, 981-995.
24. Thakur, V.; Pritchard, M.T.; McMullen, M.R.; Wang, Q.; Nagy, L.E. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J. Leukoc. Biol. 2006, 79, 1348-1356.
25. Butura, A.; Nilsson, K.; Morgan, K.; Morgan, T.R.; French, S.W.; Johansson, I.; Schuppe-Koistinen, I.; Ingelman-Sundberg, M. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J. Hepatol. 2009, 50, 572-583.
26. Qin, L.; He, J.; Hanes, R.N.; Pluzarev, O.; Hong, J.S.; Crews, F.T. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J. Neuroinflammation 2008, 5, 10.
27. Mundt, B.; Wirth, T.; Zender, L.; Waltemathe, M.; Trautwein, C.; Manns, M.P.; Kuhnel, F.; Kubicka, S. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut 2005, 54, 1590-1596.
28. Pritchard, M.T.; McMullen, M.R.; Stavitsky, A.B.; Cohen, J.I.; Lin, F.; Medof, M.E.; Nagy, L.E. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 2007, 132, 1117-1126.
29. Arteel, G.E. Silencing a killer among us: ethanol impairs immune surveillance of activated stellate cells by natural killer cells. Gastroenterology 2008, 134, 351-353.
30. Stewart, S.; Prince, M.; Bassendine, M.; Hudson, M.; James, O.; Jones, D.; Record, C.; Day, C.P. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J. Hepatol. 2007, 47, 277-283.
31. Cotrim, H.P.; Freitas, L.A.; Alves, E.; Almeida, A.; May, D.S.; Caldwell, S. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur. J. Gastroenterol. Hepatol. 2009, 21, 969-972.
32. Butterworth, R.F. Hepatic encephalopathy-A serious complication of alcoholic liver disease. Alcohol Res. Health 2003, 27, 143-145.
33. Bergheim, I.; McClain, C.J.; Arteel, G.E., Treatment of alcoholic liver disease. Dig. Dis. 2005, 23, 275-284.
34. Angulo, P. Noninvasive assessment of fibrosis and steatosis in NASH and ASH. Gastroenterol. Clin. Biol. 2009, 33, 940-948.
35. Tiniakos, D.G. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients. Gastroenterol. Clin. Biol. 2009, 33, 930-939.
36. Sebastiani, G. Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J. Gastroenterol. 2009, 15, 2190-2203.
37. Liaw, Y.F.; Chu, C.M. Hepatitis B virus infection. Lancet 2009, 373, 582-592.
38. Forrest, E. H.; Evans, C.D.; Stewart, S.; Phillips, M.; Oo, Y.H.; McAvoy, N.C.; Fisher, N.C.; Singhal, S.; Brind, A.; Haydon, G.; O'Grady, J.; Day, C.P.; Hayes, P.C.; Murray, L.S.; Morris, A.J. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005, 54, 1174-1179.
39. Ong, J.P.; Mullen, K.D. Hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001, 13, 325-334.
40. Jonas, S.; Al-Abadi, H.; Benckert, C.; Thelen, A.; Hippler-Benscheid, M.; Saribeyoglu, K.; Radtke, B.; Pratschke, J.; Neuhaus, P. Prognostic significance of the DNA-index in liver transplantation for hepatocellular carcinoma in cirrhosis. Ann. Surg. 2009, 250, 1008-1013.
41. Sheth, M.; Riggs, M.; Patel, T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol. 2002, 2, 2.
42. Neuberger, J., Developments in liver transplantation. Gut 2004, 53, 759-768.
43. Johnson, B.A., Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem. Pharmacol. 2008, 75, 34-56.
44. Ji, D.; Gilpin, N.W.; Richardson, H.N.; Rivier, C.L.; Koob, G.F., Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav. Pharmacol. 2008, 19, 1-12.
45. Anton, R.F.; Oroszi, G.; O'Malley, S.; Couper, D.; Swift, R.; Pettinati, H.; Goldman, D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch. Gen. Psychiatry 2008, 65, 135-144.
46. Anton, R.F.; Myrick, H.; Baros, A.M.; Latham, P.K.; Randall, P.K.; Wright, T.M.; Stewart, S.H.; Waid, R.; Malcolm, R. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J. Clin. Psychopharmacol. 2009, 29, 334-342.
47. Newton, B.W.; Russell, W.K.; Russell, D.H.; Ramaiah, S.K.; Jayaraman, A. Liver proteome analysis in a rodent model of alcoholic steatosis. J. Proteome. Res. 2009, 8, 1663-1671.
48. Anton, R.F.; O'Malley, S.S.; Ciraulo, D.A.; Cisler, R.A.; Couper, D.; Donovan, D.M.; Gastfriend, D.R.; Hosking, J.D.; Johnson, B.A.; LoCastro, J.S.; Longabaugh, R.; Mason, B.J.; Mattson, M.E.; Miller, W.R.; Pettinati, H.M.; Randall, C.L.; Swift, R.; Weiss, R.D.; Williams, L.D.; Zweben, A. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: A randomized controlled trial. JAMA 2006, 295, 2003-2017.
49. Groh, D.R.; Jason, L.A.; Keys, C.B. Social network variables in alcoholics anonymous: A literature review. Clin. Psychol. Rev. 2008, 28, 430-450.